Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19
暂无分享,去创建一个
Yongxiang Yi | Zhiliang Hu | Yishan Zheng | Rongrong Pang | Xiang Xue | Libo Zhang | Yudong Dai | Jingjing Bao | Sheng Ye | Qiang Fu
[1] Yuan Shi,et al. Convalescent plasma as a potential therapy for COVID-19 , 2020, The Lancet Infectious Diseases.
[2] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[3] Yunhui Liu,et al. Potential interventions for novel coronavirus in China: A systematic review , 2020, Journal of medical virology.
[4] T. Velavan,et al. The COVID‐19 epidemic , 2020, Tropical medicine & international health : TM & IH.
[5] P. Horby,et al. Specificity, kinetics and longevity of antibody responses to avian influenza A(H7N9) virus infection in humans , 2020, Journal of Infection.
[6] M. Müller,et al. Challenges of Convalescent Plasma Infusion Therapy in Middle East Respiratory Coronavirus Infection: A Single Centre Experience , 2018, Antiviral therapy.
[7] Sung‐Han Kim,et al. Case Report: Use of Plasma Exchange Followed by Convalescent Plasma Therapy in a Critically Ill Patient with Severe Fever and Thrombocytopenia Syndrome-Associated Encephalopathy: Cytokine/Chemokine Concentrations, Viral Loads, and Antibody Responses. , 2018, The American journal of tropical medicine and hygiene.
[8] Samantha E. Zak,et al. Anti–Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease , 2018, The Journal of infectious diseases.
[9] W. Paxton,et al. Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone , 2018, Transfusion.
[10] O. Garraud. Use of convalescent plasma in Ebola virus infection. , 2017, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[11] F. Hayden,et al. Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia , 2016, Emerging infectious diseases.
[12] Debopam Samanta,et al. Focal seizure associated with human parvovirus B19 infection in a non-encephalopathic child , 2016, World Journal of Pediatrics.
[13] Lanjuan Li,et al. Successful treatment of avian-origin influenza A (H7N9) infection using convalescent plasma. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[14] S. Mishra,et al. Seroprevalence of TORCH infections in antenatal and HIV positive patient populations. , 2015, Medical journal, Armed Forces India.
[15] W. Lim,et al. The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis , 2014, The Journal of infectious diseases.
[16] Abdulghani Mohamed Alsamarai,et al. Cytomegalovirus seroprevalence in women with bad obstetric history in Kirkuk, Iraq. , 2014, Journal of infection and public health.